This document discusses guidelines for classifying, reporting, controlling, and qualifying impurities in new drug substances. It defines types of impurities including organic, inorganic, and residual solvents. It provides thresholds for reporting, identifying, and qualifying impurities based on maximum daily dose. It also outlines specifications for listing impurities and qualification process. Analytical procedures and validation are also addressed.